Physiologic Effects of Sleep Restriction



Status:Recruiting
Conditions:Insomnia Sleep Studies
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - 40
Updated:3/24/2019
Start Date:October 2011
End Date:April 2021
Contact:CPL Lab
Email:cplsleep@mayo.edu

Use our guide to learn which trials are right for you!

Evidence suggests a relationship between sleep deprivation and cardiovascular disease. The
investigators wish to determine whether 9 nights of modest sleep restriction results in
activation of cardiovascular disease mechanisms, thus potentially increasing the risk of
cardiovascular disease. The investigators hypothesize that sleep restriction will result in
elevated blood pressure, inflammation, and neurocognitive deficits.

Evidence suggests a relationship between sleep deprivation and cardiovascular disease.
Voluntary sleep restriction is common, with 28% of the US adult population reports getting 6
or fewer hours of sleep per night, and those who do are 24% more likely to have
cardiovascular disease and have twice the risk of hypertension. Insufficient sleep may
conceivably be one of the most common, and most preventable, cardiovascular risk factors. The
investigators wish to determine whether 9 nights of modest sleep restriction results in
activation of cardiovascular disease mechanisms, thus potentially increasing the risk of
cardiovascular disease. The investigators will combine our cardiovascular studies with
state-of-the art sleep monitoring and neurocognitive tests to provide unambiguous data on the
physiologic effects of sleep restriction. Together, the investigators findings will help
explain whether the reduced sleep duration in the general population may be contributing to
the current epidemic of cardiovascular disease, and suggest strategies to reduce this risk.

Inclusion Criteria:

- Age 18-40 years

- No chronic medical conditions other than seasonal or environmental allergies

- On no prescription medications other than second generation antihistamines
(Cetirizine, Fexofenadine, Desloratadine, Loratadine, etc), oral contraceptive pills,
or intrauterine devices.

- BMI 18.5-35 kg/m2

- Both normotensive and prehypertensive people are eligible and will be studied

- Not a current smoker or tobacco user

- Not pregnant or breast feeding and not intending to become pregnant or breast feed

Exclusion Criteria:

- The investigators will exclude subjects who have any medical or psychiatric disorders

- History of anxiety or depression, and those taking any medications other than
non-sedating antihistamines or oral contraceptives.

- Those found to have depression on a depression screening tool (BDI-II) will be
excluded. Current smokers will be excluded.

- All female subjects will undergoing a screening pregnancy test and excluded if
positive.

- Subjects found to have significant sleep disorders will be excluded.
We found this trial at
1
site
Rochester, Minnesota 55905
Principal Investigator: Virend K Somers, MD, PhD
?
mi
from
Rochester, MN
Click here to add this to my saved trials